Cargando…

Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin

Background. Treatment with omalizumab, a humanized recombinant monoclonal anti-IgE antibody, results in clinical efficacy in patients with Chronic Spontaneous Urticaria (CSU). The mechanism of action of omalizumab in CSU has not been elucidated in detail. Objectives. To determine the effects of omal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metz, Martin, Staubach, Petra, Bauer, Andrea, Brehler, Randolf, Gericke, Janine, Kangas, Michael, Ashton-Chess, Joanna, Jarvis, Philip, Georgiou, Panayiotis, Canvin, Janice, Hillenbrand, Rainer, Erpenbeck, Veit J., Maurer, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399592/ https://www.ncbi.nlm.nih.gov/pubmed/28435464 http://dx.doi.org/10.7150/thno.18304

Ejemplares similares

Response of FcεRI‐bearing leucocytes to omalizumab in chronic spontaneous urticaria
por: Alizadeh Aghdam, Mehran, et al.
Publicado: (2020)

In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria
por: Moñino‐Romero, Sherezade, et al.
Publicado: (2023)

Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria
por: Endo, Takahiro, et al.
Publicado: (2020)

Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2019)

Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticaria
por: Bartko, Ewa A., et al.
Publicado: (2022)

A Rapid Method of Detecting Autoantibody against FcεRIα for Chronic Spontaneous Urticaria
por: Lee, Mey-Fann, et al.
Publicado: (2014)

Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
por: Humbert, Marc, et al.
Publicado: (2013)

Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria
por: Jang, Jae-Hyuk, et al.
Publicado: (2022)

An Interaction Library for the FcεRI Signaling Network
por: Chylek, Lily A., et al.
Publicado: (2014)

Suppression of Basophil FcεRI Activation by Serum from Active Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Subjects
por: Sterba, Patricia M, et al.
Publicado: (2015)

Ethanol Inhibits High-Affinity Immunoglobulin E Receptor (FcεRI) Signaling in Mast Cells by Suppressing the Function of FcεRI-Cholesterol Signalosome
por: Draberova, Lubica, et al.
Publicado: (2015)

Regulation of Trafficking and Signaling of the High Affinity IgE Receptor by FcεRIβ and the Potential Impact of FcεRIβ Splicing in Allergic Inflammation
por: Arthur, Greer K., et al.
Publicado: (2022)

Negative Regulation of FcεRI-mediated Degranulation by CD81
por: Fleming, Tony J., et al.
Publicado: (1997)

Selection and characterization of FcϵRI phospho-ITAM specific antibodies
por: Velappan, Nileena, et al.
Publicado: (2019)

FcεRI: A Master Regulator of Mast Cell Functions
por: Nagata, Yuka, et al.
Publicado: (2022)

The Crosstalk between FcεRI and Sphingosine Signaling in Allergic Inflammation
por: Jo, Hyein, et al.
Publicado: (2022)

Healthcare Resource Utilization in Patients Receiving Omalizumab for Allergic Asthma in a Real-World Setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2014)

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H(1) Antihistamines: A Randomized, Placebo-Controlled Study
por: Saini, Sarbjit S, et al.
Publicado: (2015)

Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy?
por: Metz, Martin, et al.
Publicado: (2021)

Observing Fcεri Signaling from the Inside of the Mast Cell Membrane
por: Wilson, Bridget S., et al.
Publicado: (2000)

Fine-Tuning of Mast Cell Activation by FcεRIβ Chain
por: Ra, Chisei, et al.
Publicado: (2012)

The Role Played by Mitochondria in FcεRI-Dependent Mast Cell Activation
por: Chelombitko, Maria A., et al.
Publicado: (2020)

TIRF Microscope Image Sequences of Fluorescent IgE-FcεRI Receptor Complexes inside a FcεRI-Centric Synapse in RBL-2H3 Cells
por: Drawbond, Rachel, et al.
Publicado: (2019)

Omalizumab rapidly improves angioedema‐related quality of life in adult patients with chronic spontaneous urticaria: X‐ACT study data
por: Staubach, P., et al.
Publicado: (2017)

The FcεRI signaling cascade and integrin trafficking converge at patterned ligand surfaces
por: Wakefield, Devin L., et al.
Publicado: (2017)

Differential mast cell outcomes are sensitive to FcεRI-Syk binding kinetics
por: Schwartz, Samantha L., et al.
Publicado: (2017)

Corrigendum: The Role Played by Mitochondria in FcϵRI-Dependent Mast Cell Activation
por: Chelombitko, Maria A., et al.
Publicado: (2020)

Docking of Syk to FcεRI is enhanced by Lyn but limited in duration by SHIP1
por: Kanagy, William K., et al.
Publicado: (2022)

New Mechanistic Advances in FcεRI-Mast Cell–Mediated Allergic Signaling
por: Li, Yang, et al.
Publicado: (2022)

Regulation of Syk activity by antiviral adaptor MAVS in FcεRI signaling pathway
por: Kawakami, Yuko, et al.
Publicado: (2023)

Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response
por: Gimeno, Ramón, et al.
Publicado: (2023)

Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
por: Metz, Martin, et al.
Publicado: (2020)

Omalizumab for chronic urticaria in Latin America
por: Wilches, Paul, et al.
Publicado: (2016)

Urticaria and angioedema as possible reactions of omalizumab
por: Ozbagcivan, Ozlem, et al.
Publicado: (2018)

Rcan1 negatively regulates FcεRI-mediated signaling and mast cell function
por: Yang, Yong Jun, et al.
Publicado: (2009)

Cigarette Smoke Suppresses the Surface Expression of c-kit and FcεRI on Mast Cells
por: Givi, M. E., et al.
Publicado: (2013)

Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation
por: Phong, Binh L., et al.
Publicado: (2015)

FcεRI γ-Chain Negatively Modulates Dectin-1 Responses in Dendritic Cells
por: Pan, Yi-Gen, et al.
Publicado: (2017)

SLAP Is a Negative Regulator of FcεRI Receptor-Mediated Signaling and Allergic Response
por: Sharma, Namit, et al.
Publicado: (2019)

FcεRI Signaling in the Modulation of Allergic Response: Role of Mast Cell-Derived Exosomes
por: Lecce, Mario, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r06vvje7v5e020o1laag14g1eb